Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP).

Diabetologia. 2006 Feb;49(2):289-97. Epub 2006 Jan 4.

PMID:
16391903
2.

Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).

Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC, Shetty AS.

Diabetologia. 2009 Jun;52(6):1019-26. doi: 10.1007/s00125-009-1315-x. Epub 2009 Mar 10.

PMID:
19277602
3.

Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).

Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z.

Diabetes Care. 2007 Oct;30(10):2548-52. Epub 2007 Aug 1.

PMID:
17670917
4.

Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.

Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V.

Diabetes Res Clin Pract. 2007 May;76(2):215-8. Epub 2006 Sep 18.

PMID:
16982107
5.

Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).

Ramachandran A, Arun N, Shetty AS, Snehalatha C.

Diabetes Care. 2010 Oct;33(10):2164-8. doi: 10.2337/dc09-1150. Epub 2010 Jun 2.

6.

Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).

Snehalatha C, Mary S, Selvam S, Sathish Kumar CK, Shetty SB, Nanditha A, Ramachandran A.

Diabetes Care. 2009 Oct;32(10):1796-801. doi: 10.2337/dc09-0676. Epub 2009 Jul 8.

7.

Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.

Snehalatha C, Mary S, Joshi VV, Ramachandran A.

Diab Vasc Dis Res. 2008 Mar;5(1):25-9. doi: 10.3132/dvdr.2008.005.

PMID:
18398809
8.
9.

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

Florez H, Temprosa MG, Orchard TJ, Mather KJ, Marcovina SM, Barrett-Connor E, Horton E, Saudek C, Pi-Sunyer XF, Ratner RE, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Obes Metab. 2014 Apr;16(4):326-33. doi: 10.1111/dom.12220. Epub 2013 Oct 29.

10.

Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial.

Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG.

Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8. doi: 10.1016/S2213-8587(13)70067-6. Epub 2013 Sep 11.

PMID:
24622367
11.

Early improvement predicts reduced risk of incident diabetes and improved cardiovascular risk in prediabetic Asian Indian men participating in a 2-year lifestyle intervention program.

Nanditha A, Ram J, Snehalatha C, Selvam S, Priscilla S, Shetty AS, Arun R, Godsland IF, Johnston DG, Ramachandran A.

Diabetes Care. 2014 Nov;37(11):3009-15. doi: 10.2337/dc14-0407. Epub 2014 Sep 11.

PMID:
25216506
12.

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. doi: 10.1210/jc.2008-0772. Epub 2008 Sep 30.

13.

Relationship of body size and shape to the development of diabetes in the diabetes prevention program.

Diabetes Prevention Program Research Group.

Obesity (Silver Spring). 2006 Nov;14(11):2107-17.

14.

Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.

Zinman B, Harris SB, Gerstein HC, Young TK, Raboud JM, Neuman J, Hanley AJ.

Diabetes Obes Metab. 2006 Sep;8(5):531-7.

PMID:
16918588
15.

The oral disposition index is a strong predictor of incident diabetes in Asian Indian prediabetic men.

Ram J, Snehalatha C, Selvam S, Nanditha A, Shetty AS, Godsland IF, Johnston DG, Ramachandran A.

Acta Diabetol. 2015 Aug;52(4):733-41. doi: 10.1007/s00592-015-0718-z. Epub 2015 Feb 12.

PMID:
25670243
16.

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

Ann Intern Med. 2005 Mar 1;142(5):323-32.

17.

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV.

Diabetes Care. 1997 Apr;20(4):537-44.

PMID:
9096977
18.

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group.

Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. doi: 10.1016/S2213-8587(15)00291-0. Epub 2015 Sep 13.

19.

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM.

Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29. Erratum in: Lancet. 2009 Dec 19;374(9707):2054.

20.

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R.

J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81.

Supplemental Content

Support Center